FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

1270711000001101: Co-beneldopa 25mg/100mg dispersible tablets 100 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22482901000001114 Co-beneldopa 25mg/100mg dispersible tablets 100 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22483001000001117 Co-beneldopa 25mg/100mg dispersible tablets 100 tablet en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
43625501000001110 Co-beneldopa 25mg/100mg dispersible tablets sugar free 100 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has VMP Co-beneldopa 25mg/100mg dispersible tablets sugar free true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has VMP Co-beneldopa 25mg/100mg dispersible tablets sugar free false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has dispensed dose form Dispersible tablet true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Is pack of Co-beneldopa 25mg/100mg dispersible tablet false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has active ingredient Levodopa false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has active ingredient Benserazide false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has active ingredient Benserazide hydrochloride false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has VMP Co-beneldopa 25mg/100mg dispersible tablet false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has specific active ingredient Benserazide hydrochloride true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has specific active ingredient Levodopa true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has basis of strength substance Benserazide true Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Has dispensed dose form Dispersible tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Madopar 125 dispersible tablets (Roche Products Ltd) 100 tablet Is a True Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Inferred relationship Existential restriction modifier
Madopar 100mg/25mg dispersible tablets (Waymade Healthcare Plc) 100 tablet Is a True Co-beneldopa 25mg/100mg dispersible tablets 100 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start